Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II, Randomized Multi-Center, Double-Blind Study of Tranilast With Concomitant Methotrexate (MTX) Compared to MTX Alone in Patients With Active Rheumatoid Arthritis (RA)

NCT00882024 is registered in ClinicalTrials.gov with Nuon Therapeutics, Inc. as lead sponsor.

NCT NCT00882024
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00882024 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II, Randomized Multi-Center, Double-Blind Study of Tranilast With Concomitant Methotrexate (MTX) Compared to MTX Alone in Patients With Active Rheumatoid Arthritis (RA)
Lead sponsor
Nuon Therapeutics, Inc.
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2009
Completion date
December 31, 2010
Enrollment
250 (estimated)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

active rheumatoid arthritis